medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
47条
与
stage
有关的结果
Management of Targeted Therapies in Cancer Patients with Chronic Kidney Disease, Or on Haemodialysis: an Associazione Italiana Di Oncologia Medica (AIOM)/Societa’ Italiana Di Nefrologia (SIN) Multidisciplinary Consensus Position Paper
2019年 发布于
Critical Reviews in Oncology/Hematology
140卷 第期
所属人体系统:
其他
|
治疗方案
Associazione Italiana Di Oncologia Medica
Societa’ Italiana Di Nefrologia
Cancer
Chronic Kidney Disease
ESRD
End-
stage
Renal Disease
Hemodialysis
Kidney Failure
Renal Impairment
Targeted Therapy.
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-
stage
Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-
stage
Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors
Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology
2019年 发布于
Journal of Gynecology Obstetrics and Human Reproduction
48卷 第6期
所属人体系统:
其他
|
腹膜肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-
stage
Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-
stage
Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). for FIGO Stages III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancer (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When Metastatic Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B).
指南简介
原文链接
Treatment of Patients with Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
2020年 发布于
American Society of Clinical Oncology
卷 第期
所属人体系统:
消化
|
结直肠肿瘤
American Society of Clinical Oncology
Colorectal Cancer
Late-Stage
Resource-Stratified
Treatment
指南简介
原文链接
Breast Cancer Screening and Diagnosis at the End of the COVID-19 Confinement Period, Practical Aspects and Prioritization Rules: Recommendations of 6 French Health Professionals Societies
2020年 发布于
Bull Cancer
107卷 第6期
所属人体系统:
生殖
|
乳腺肿瘤
De La Société Française De Sénologie Et Pathologie Mammaire
La Société Française De Radiologie
La Société Française D’Imagerie De La Femme
Le Collège Des Enseignants De Radiologie De France
FORCOMED Et Les Pour La Pratique Clinique De Nice-Saint Paul De Vence.
Breast
COVID-19
Diagnosis
Diagnostic
Dépi
stage
Screening
Sein.
指南简介
原文链接
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC
2020年 发布于
J Thorac Oncol
15卷 第3期
所属人体系统:
呼吸
|
肺癌
Asian Thoracic Oncology Research Group
Asian
Consensus Statement
Stage III NSCLC.
指南简介
原文链接
Therapy for Stage IV Non-Small-Cell Lung Cancer without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
2020年 发布于
Journal of Clinical Oncology
39卷 第9期
所属人体系统:
呼吸
|
肺癌
American Society of Clinical Oncology and Ontario Health (Cancer Care Ontario)
Stage IV
Non-small-cell Lung Cancer
Driver Alterations
Therapy
Guideline
指南简介
原文链接
Treatment of Patients with Late-stage Colorectal Cancer: ASCO Resource-stratified Guideline
2020年 发布于
JCO Glob Oncol
6卷 第期
所属人体系统:
消化
|
结直肠肿瘤
American Society of Clinical Oncology
Colorectal Cancer
Late-
stage
Treatment
Guideline
指南简介
原文链接
Therapy for Stage IV Non–Small-Cell Lung Cancer without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
2020年 发布于
American Society of Clinical Oncology
卷 第期
所属人体系统:
呼吸
|
肺癌
American Society of Clinical Oncology
Non-Small Cell Lung Cancer
Stage IV
Therapy
Driver Alterations
Chemotherapy
Adjuvant
Immunosuppressive Agents
指南简介
原文链接
Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Surgical Management of Advanced Stages of Borderline Ovarian Tumours
2020年 发布于
Gynecol Obstet Fertil Senol
48卷 第3期
所属人体系统:
生殖
|
卵巢肿瘤
Collège National Des Gynécologues Et Obstétriciens Français
Advanced Stages
Borderline Ovarian Tumors
Chirurgie
Fertility Sparing
Préservation De La Fertilité
Stades Avancés
Surgery
Tumeur Frontière De L’ovaire.
指南简介
原文链接
The Mexican Consensus on the Detection and Treatment of Early Gastric Cancer
2020年 发布于
Revista De Gastroenterologia De Mexico
85卷 第1期
所属人体系统:
消化
|
胃癌
无
Cáncer Gástrico
Displasia
Dysplasia
Early-
stage
Gastric Cancer
Helicobacter Pylori
Incipiente
Metaplasia
Mexico
México.
指南简介
原文链接
Institut Curie Guidelines on Breast Target Volume Delineation for Patients Treated in Lateral Position
2020年 发布于
Cancer Radiother
24卷 第8期
所属人体系统:
生殖
|
乳腺肿瘤
无
Breast-conserving Surgery
Cancer Du Sein
Chirurgie Conservatrice
Décubitus Latéral Isocentrique
Délinéation
Early-
stage
Breast Cancer
Lateral Position
Radiotherapy
Radiothérapie
Sein
Stade Précoce
Volume
Volume Delineation.
指南简介
原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma
2021年 发布于
Current Oncology
28卷 第2期
所属人体系统:
其他
|
腹膜肿瘤
Ontario Health (Cancer Care Ontario)
Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II
III
Or IV Epithelial Ovary
Fallopian Tube
Or Primary Peritoneal Carcinoma Including All Histological Types.
Methods: Consistent with the Program in Evidence-based Program's Standardized Approach
MEDLINE
EMBASE
PubMed
Cochrane Library
and PROSPERO (the International Prospective Register of Systematic Reviews) Databases
and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers.
Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall
Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy
We Recommended Olaparib (Recommendation)
Niraparib (Weak Recommendation)
Veliparib (Weak Recommendation)
and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian
Fallopian Tube
Or Primary Peritoneal Carcinoma
Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available
the Recommendations Will Be Updated as Soon as Possible.
指南简介
原文链接
Clinical Practice Guidelines for Sentinel Lymph Node Biopsy in Patients with Early-stage Breast Cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2021
2021年 发布于
Chin Med J (Engl)
134卷 第8期
所属人体系统:
生殖
|
乳腺肿瘤
Chinese Society of Breast Surgery
Early-
stage
Breast Cancer
Sentinel Lymph Node Biopsy
Guideline
指南简介
原文链接
Individualizing Surveillance Mammography for Older Patients after Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement
2021年 发布于
JAMA Oncology
7卷 第4期
所属人体系统:
生殖
|
乳腺肿瘤
International Society of Geriatric Oncology
Early-
stage
Breast Cancer
Older Patients
Treatment
Individualizing Surveillance Mammography
Consensus
指南简介
原文链接
Breast Conservation and Axillary Management after Primary Systemic Therapy in Patients with Early-stage Breast Cancer: the Lucerne Toolbox
2021年 发布于
Lancet Oncol
22卷 第1期
所属人体系统:
生殖
|
乳腺肿瘤
European Society of Surgical Oncology
European Society for Radiotherapy and Oncology;European Society of Breast Imaging;European Society of Breast Cancer Specialists
European School of Oncology;European Society for Medical Oncology; EUROPA DONNA–The European Breast Cancer Coalition
Austrian Breast and Colorectal Cancer Study Group
International Breast Cancer Study Group
German Breast Group
Swiss Working Group for Clinical Cancer Research
Swiss Society of Senology
and Hirslanden Network of Breast Cancer Centers
Early-
stage
Breast Cancer
Systemic Therapy
Breast Conservation
Axillary Management
Guideline
指南简介
原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma
2021年 发布于
Current Oncology
28卷 第2期
所属人体系统:
生殖
|
输卵管癌
Ontario Health (Cancer Care Ontario)
Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II
III
Or IV Epithelial Ovary
Fallopian Tube
Or Primary Peritoneal Carcinoma Including All Histological Types.
Methods: Consistent with the Program in Evidence-based Program's Standardized Approach
MEDLINE
EMBASE
PubMed
Cochrane Library
and PROSPERO (the International Prospective Register of Systematic Reviews) Databases
and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers.
Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall
Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy
We Recommended Olaparib (Recommendation)
Niraparib (Weak Recommendation)
Veliparib (Weak Recommendation)
and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian
Fallopian Tube
Or Primary Peritoneal Carcinoma
Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available
the Recommendations Will Be Updated as Soon as Possible.
指南简介
原文链接
Cervical Cancer
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统:
生殖
|
子宫肿瘤
National Comprehensive Cancer Network
Cervical Cancer
stage
surveillance
recurrence
pathology
imaging
radiation Therapy
systemic Therapy
指南简介
原文链接
Ovarian Cancer(Guideline for Patients)
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统:
生殖
|
卵巢肿瘤
National Comprehensive Cancer Network
Patient
Epithelial
Ovarian Cancer
treatment
stage
指南简介
原文链接
Therapy for Stage IV Non-Small-Cell Lung Cancer with Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
2021年 发布于
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
39卷 第9期
所属人体系统:
呼吸
|
肺癌
American Society of Clinical Oncology
Ontario Health (Cancer Care Ontario)
Stage IV
Non-small-cell Lung Cancer
Therapy
Driver Alterations
Guideline
指南简介
原文链接
首页
上一页
1
2
3
下一页
尾页
共47条,每页显示
20条
50条
100条
跳转至第
页
确定